Sunshine Heart close to resuming patient enrollment in C-Pulse study
Seeking Alpha - at Seeking Alpha - Fri Apr 17, 8:09AM CDT
SSH: 4.33 (-0.03)
Sunshine Heart Provides Update on U.S. Pivotal Study of C-Pulse(R) Heart Assist System
GlobeNewswire - Thu Apr 16, 3:54PM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that the U.S. Food and Drug Administration (FDA) has reviewed the Company's submission regarding the COUNTER HF's U.S. pivotal study pause and requested minor protocol changes be submitted in order to receive approval to resume patient enrollment. The FDA did not indicate concerns regarding safety of the device and requested the updated protocol include information on several minor items, the most significant of which are the details regarding the Company's proposal to incorporate a Physician Subject Selection Committee. Furthermore, the Data Safety Monitoring Board (DSMB), reviewed COUNTER HF's data and recommended continuing the Study.
SSH: 4.33 (-0.03)
Sunshine Heart's (SSH) CEO Dave Rosa on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Mar 17, 2:34PM CDT
SSH: 4.33 (-0.03)
Premarket Gainers / Losers as of 9:15 am
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 8:19AM CDT
SD: 1.84 (unch), SSH: 4.33 (-0.03), PLUG: 2.65 (-0.02), BBX: 19.14 (+0.22), IMNP: 1.98 (-0.02), MGM: 22.00 (-0.08), DSW: 39.14 (+1.37), VEEV: 27.17 (-0.24), ESPR: 104.60 (-4.29), CYTX: 0.99 (+0.01), BDE: 9.05 (-0.20), ARTX: 2.85 (-0.07), ANTH: 5.20 (+0.31), WYY: 1.52 (-0.03), CJJD: 4.01 (+0.27), DSCO: 1.24 (-0.02)
Sunshine Heart (SSH) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Mar 17, 7:55AM CDT
SSH: 4.33 (-0.03)
Sunshine Heart ups revenues 400% in FY14
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 7:41AM CDT
SSH: 4.33 (-0.03)
Sunshine Heart beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 4:41AM CDT
SSH: 4.33 (-0.03)
Sunshine Heart Announces Fourth Quarter and Twelve Months 2014 Financial Results and Provides Corporate Update
Thomson Reuters ONE - Tue Mar 17, 4:30AM CDT
EDEN PRAIRIE, Minn., March 17, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) today announced its financial results and provided a corporate update for the fourth quarter and year ended December 31, 2014. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on its ongoing clinical studies.
SSH: 4.33 (-0.03)
Sunshine Heart to Release Fourth Quarter and Year-End 2014 Results on March 17, 2015
GlobeNewswire - Tue Mar 10, 4:30AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) today announced that its fourth quarter and year-end 2014 results will be released on Tuesday, March 17, 2015, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 4.33 (-0.03)
Sunshine Clouds Over After Patient Deaths
EP Vantage - at Seeking Alpha - Mon Mar 09, 2:24PM CDT
Suspending a pivotal trial is always a worry. When it is a trial of a company’s sole device, and the halt is due to four of the first 20 patients enrolled dying, it is more than a worry. Shares in Sunshine Heart (NASDAQ: SSH ) fell 25% on...
SSH: 4.33 (-0.03), THOR: 42.31 (-0.46), HTWR: 78.80 (-0.82)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 11:45AM CST
SSH: 4.33 (-0.03), ONCY: 0.75 (-0.05), LTM: 71.46 (+0.02), LEDS: 0.88 (-0.02), CLDN: 13.68 (-0.26), AXN: 1.71 (+0.02), EXAS: 21.98 (-1.08), DRRX: 2.11 (-0.46), DRAD: 4.53 (-0.06), BLRX: 2.10 (-0.02), GENE: 4.70 (-0.13), OREX: 7.36 (-0.08), ICEL: 16.48 (-0.02), BORN: 1.35 (+0.05), DMD: 6.55 (-0.13), AVEO: 1.92 (-0.08), CALA: 13.41 (-0.35), MTL: 1.29 (+0.02), CKP: 10.84 (-0.04), ERII: 3.22 (-0.15)
Sunshine Heart (SSH) Stock Drops Today After Suspending Study Enrollment
at The Street - Fri Mar 06, 9:35AM CST
Shares of Sunshine Heart (SSH) are down after the company temporarily suspended enrollment for a study of its signature C-Pulse system.
SSH: 4.33 (-0.03)
Sunshine Heart suspends enrollment in C-Pulse trial after four deaths
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 6:38AM CST
SSH: 4.33 (-0.03)
Sunshine Heart: There Is A Silver Lining To Those Clouds
Robert Honeywill - at Seeking Alpha - Wed Mar 04, 6:00AM CST
Article series This article is a continuation of my series of articles developing a long term investment strategy based on an area of unmet need in the health sector, viz., enduring and effective therapies for late stage heart failure (see here , ...
SSH: 4.33 (-0.03), THOR: 42.31 (-0.46), HTWR: 78.80 (-0.82)
Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec
PR Newswire - Mon Mar 02, 8:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
ELOS: 12.05 (-0.04), SSH: 4.33 (-0.03), SPNC: 26.52 (-8.18), THOR: 42.31 (-0.46), SURG: 5.24 (+0.02)
Sunshine Heart up premarket on prospects of shorter study of heart assist device
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 7:45AM CST
SSH: 4.33 (-0.03)
Sunshine Heart, Inc. Secures Up to $10 Million in Growth Capital From Silicon Valley Bank
GlobeNewswire - Thu Feb 19, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) (the "Company" or "Sunshine Heart"
SSH: 4.33 (-0.03), SIVB: 128.76 (-1.97)